Joinn Laboratories (China) Co Ltd

603127

Company Profile

  • Business description

    Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non-Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

  • Contact

    A5 Rongjing East Street
    Beijing Economic-Technological Development Area
    Beijing100176
    CHN

    T: +86 1067869966

    https://www.joinnlabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    2,652

Stocks News & Analysis

stocks

More gas left in the tank for ASX highflyer

Shares jumped after results and are screening as overvalued.
stocks

Does BHP have a cost problem?

Increasing capital expenditures on Jensen potash project.
stocks

Ahead of Earnings, is Apple stock a buy, a sell, or fairly valued?

Following strong holiday sales and a recent AI deal, here’s what we’re watching for in Apple’s earnings report.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,189.9015.700.17%
CAC 408,131.1511.90-0.15%
DAX 4024,933.0832.370.13%
Dow JONES (US)49,460.25361.540.74%
FTSE 10010,148.855.410.05%
HKSE26,765.52135.560.51%
NASDAQ23,638.19136.950.58%
Nikkei 22552,885.25803.64-1.50%
NZX 50 Index13,460.7496.13-0.71%
S&P 5006,959.9744.360.64%
S&P/ASX 2008,860.1015.000.17%
SSE Composite Index4,132.603.56-0.09%

Market Movers